Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Myota has raised $4.5 million in a funding round to expand its B2B sales in the US and Europe, enhance its direct-to-consumer business, and advance clinical research.
Amount Raised
$4.5 Million
Round Type
Seed
Blue BellInformation TechnologyInvestors
Description
Myota develops fibre blends aimed at improving short-chain fatty acid production across various gut microbiomes. The new funding will help the company scale its operations and meet growing demand for clinically validated fibre. Co-founder Kat Stennett highlighted the importance of effective fibre in human health. Investor Yoni Glickman noted that consumer interest in fibre supplementation is rising, prompting this timely investment.
Related People
Funding Insights
Based on industry dataWatching Myota? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan